Main Article Content
The second deadliest disease faced by humanity in this era is considered as Urinary tract infection. Pathogens affecting the genitourinary system include bacteria, virus, fungi, protozoan etc. Among them E-Coli and Staphylococcus are most common. It may cause organ damage which may lead to death. The symptoms are similar to Mootrakruchra narrated in Ayurveda and the management is also found very useful, especially, in this scenario of experiencing antibiotic resistance. This study of Shwetaparpati is one among the anecdotal evidences of success stories experienced by the Ayurvedic community. Pre and post test case reports selected a twenty-year-old female patient diagnosed as having lower urinary tract infection for the last seven months. She was administered the drug Shwetaparpati. The duration of the treatment was for fourteen out-patient days. She was assessed before, after and on follow-up treatment for improvement using subjective and objective assessment criteria. ICD 10 CM-N39.0 is used for the selection and assessment. The subject experienced clinical symptoms and signs of increased frequency and urgency, Dysuria, abdominal pain back pain, burning micturition, tiredness, bacteriuria (Staphylococcus-Sp), pyuria, and hematuria. Initial symptoms were found reduced. On the follow-up it concluded that the bacteria disappeared completely.